The research report released on January 28 said that it maintained the overweight rating of Apt Medical Inc(688617) (688617.sh, latest price: 202.01 yuan). The reasons for rating mainly include: 1) breakthrough in electrophysiological layout and rapid growth of vascular intervention business; 2) Product R & D is advancing rapidly and international business is developing continuously; 3) Domestic substitution space is huge, and three-dimensional electrophysiology is expected to accelerate the volume. Risk tip: the risk of medical insurance fee control policy, the risk that the promotion of research projects does not meet the expectations, the risk that the construction progress of raised investment capacity does not meet the expectations, and the risk of exchange rate fluctuation.
AI comments: Apt Medical Inc(688617) obtained the attention of one Research Report of securities companies in recent month and increased its holdings of one.
